|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/28 | (2006.01) |
| A61K 31/155 | (2013.01) | ||
| A61K 31/155 | (2006.01) | ||
| A61K 9/2886 | (2013.01) | ||
| A61P 1/12 | (2006.01) | ||
| A61P 1/00 | (2018.01) | ||
| A61P 1/18 | (2006.01) | ||
| A61P 1/12 | (2018.01) | ||
| A61P 3/00 | (2006.01) | ||
| A61P 1/18 | (2018.01) | ||
| A61P 1/00 | (2006.01) | ||
| A61P 3/00 | (2018.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61P 3/04 | (2018.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 3/10 | (2018.01) |
| (11) | Number of the document | 2941245 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14702108.3 |
| Date of filing the European patent application | 2014-01-03 | |
| (97) | Date of publication of the European application | 2015-11-11 |
| (45) | Date of publication and mention of the grant of the patent | 2024-06-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/010240 |
| Date | 2014-01-03 |
| (87) | Number | WO 2014/107617 |
| Date | 2014-07-10 |
| (30) | Number | Date | Country code |
| 201361749307 P | 2013-01-05 | US |
| (72) |
BARON, Alain D. , US
FINEMAN, Mark S. , US
KIM, Terri , US
DORDUNOO, Stephen Kwaku , US
|
| (73) |
Anji Pharmaceuticals Inc. ,
245 Main Street, Cambridge, MA 02142,
US
|
| (54) | DELAYED-RELEASE COMPOSITION COMPRISING BIGUANIDE |
| DELAYED-RELEASE COMPOSITION COMPRISING BIGUANIDE |